Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that Humana Inc. (HUM) rates highest using their Acquirer's Multiple Investor model, based on the deep value strategy of Tobias Carlisle, receiving a 73% rating. While the stock passes tests for sector and quality, it fails the acquirer's multiple test, suggesting mixed signals regarding its attractiveness as a potential takeover target according to this specific deep value investment strategy.

Analysis

Humana Inc. (HUM) has been evaluated by Validea's guru fundamental report, specifically through the Acquirer's Multiple Investor model developed by Tobias Carlisle, which focuses on identifying deep value stocks as potential takeover targets. HUM, a large-cap growth stock in the Healthcare Facilities industry, received a 73% rating under this model, a score that falls below the 80% threshold typically indicating strategy interest and well below the 90% mark for strong interest. While the report indicates HUM passes criteria related to its SECTOR and overall QUALITY, it notably fails the core ACQUIRER'S MULTIPLE test itself, which is the primary valuation metric of this strategy. This specific failure, despite positive secondary checks, suggests that according to this particular deep value methodology, HUM does not currently present as a compellingly inexpensive stock or an immediate takeover candidate as per Carlisle's criteria.

Key Decisions for Investors

• Investors should interpret Humana's 73% rating and its failure on the core Acquirer's Multiple test as an indication it may not currently meet the criteria for a deep value investment or takeover target strictly under this specific model.
• While positive sector and quality assessments are noted, the failure on the key valuation metric of the Acquirer's Multiple strategy presents a significant caveat for investors considering HUM through this particular deep value lens.
• Strict adherents to Tobias Carlisle's Acquirer's Multiple strategy might therefore view HUM as not currently meeting the stringent valuation criteria for a buy signal based on these specific findings.